Literature DB >> 16181294

Primary treatment of choroidal amelanotic melanoma with photodynamic therapy.

Mark J Donaldson, Lyndell Lim, C Alex Harper, John Mackenzie, William G Campbell.   

Abstract

The management of choroidal melanoma involves a delicate balance between preserving vision and preventing metastasis. Plaque brachytherapy has become standard management of most small lesions; however, this can result in radiation retinopathy and optic neuropathy. Transpupillary thermotherapy avoids these side-effects; however, it can also result in visual loss and its effectiveness is limited in amelanotic lesions. Photodynamic therapy with verteporfin has shown promise in animal studies of choroidal melanoma, and has recently been used in the management of lesions that have failed to respond to conventional therapy. The authors report a case of primary treatment of a small choroidal amelanotic melanoma with photodynamic therapy using verteporfin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181294     DOI: 10.1111/j.1442-9071.2005.01083.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  8 in total

1.  Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma.

Authors:  I D Fabian; A W Stacey; V Papastefanou; L Al Harby; A K Arora; M S Sagoo; V M L Cohen
Journal:  Eye (Lond)       Date:  2017-03-24       Impact factor: 3.775

2.  Photodynamic therapy of symptomatic choroidal nevi.

Authors:  Luis Amselem; Kaan Gündüz; Alfredo Adan; Melisa Zişan Karslιoğlu; Amanda Rey; Noelia Sabater; Xavier Valldeperas
Journal:  Middle East Afr J Ophthalmol       Date:  2011-10

3.  Specific Targeting of Melanotic Cells with Peptide Ligated Photosensitizers for Photodynamic Therapy.

Authors:  Paul Lorenz Bigliardi; Bhimsen Rout; Aakanksha Pant; Viknish Krishnan-Kutty; Alex N Eberle; Ramasamy Srinivas; Brendan Adrian Burkett; Mei Bigliardi-Qi
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

Review 4.  Susceptibility and Resistance Mechanisms During Photodynamic Therapy of Melanoma.

Authors:  Xin-Ying Li; Liu-Chang Tan; Li-Wen Dong; Wan-Qi Zhang; Xiao-Xiao Shen; Xiao Lu; Hong Zheng; Yuan-Gang Lu
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

5.  Photodynamic therapy of melanoma by blue-light photoactivation of flavin mononucleotide.

Authors:  R A Akasov; N V Sholina; D A Khochenkov; A V Alova; P V Gorelkin; A S Erofeev; A N Generalova; E V Khaydukov
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

Review 6.  Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review.

Authors:  Nkune Williams Nkune; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

7.  Transient increased exudation after photodynamic therapy of intraocular tumors.

Authors:  Arman Mashayekhi; Carol L Shields; Jerry A Shields
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

8.  Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers - a comparative study.

Authors:  Ioana Baldea; Rodica-Mariana Ion; Diana Elena Olteanu; Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip
Journal:  Clujul Med       Date:  2015-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.